Acquisition of Complete Genomics by Chinese Company Gets Green Light

California-based DNA sequencer Complete Genomics (UNKNOWN: GNOM.DL  ) has announced that China's BGI-Shenzhen has received clearance from the Committee on Foreign Investment in the United States to proceed with buying the company. This purchase, announced on Sept. 15, has been on hold pending approval from the interdepartmental government agency, which includes representatives from the departments of Treasury, Defense, State, Commerce, and Homeland Security.

Shares of Complete Genomics opened 0.6% higher Monday, at $3.15 per share, the same price BGI-Shenzhen bid in September.

 

link


Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2173668, ~/Articles/ArticleHandler.aspx, 7/13/2014 5:36:36 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement